Brief: Medesis Pharma Creates Council For Neurodegenerative Diseases
21/11/2022 17:07
Nov 21 (Reuters) - MEDESIS PHARMA SA ALMDP.PA :
* ANNOUNCES THE CREATION OF A PERMANENT SCIENTIFIC COUNCIL
OF
EXPERTS IN NEURODEGENERATIVE DISEASES
Source text for Eikon: ID:nNDL6Clv9l
Further company coverage: ALMDP.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Medesis Pharma SA
See all newsBrief: Medesis Pharma FY EBIT Loss Widens To EUR 3.244 Mln
Brief: Medesis Pharma Signs A Partnership With Partner International
Brief: Medesis Pharma Issues Bond Financing With Maximum Potential Nominal Amount Of EUR 2.5 Mln
Brief: Medesis Pharma Creates Council For Neurodegenerative Diseases
Brief: Medesis Pharma H1 Operating Loss Widens To 1.8 Million Euros